StHealth Capital, Our #1 Ranked Emerging BDC Idea.

Newly Launched Medtech & Biotech BDC Seeking Pre-IPO Stage Investments. This is easily one of the most exciting fund managers we've come across in a...

StHealth Private Equity Medtech Fund. Alternative Investment BDC.

StHealth Capital (STHC, no symbol yet) has put together an amazing team to manage the Fund recently organized to provide investors with both yield...
DIABASENS

Diabasens® to Launch in Europe. Innovus (INNV).

"The product will be launched initially in France, the United Kingdom, Italy, Germany and Spain through our Pan-European Amazon® store, followed by local distributors...

Former Tesla Foundation Vice Chairman Joins StHealth BDC.

St Health Capital Investment Corporation is delighted to announce Dr. Robert GW Brown FAPS, FIEE, FInstP, MAE as a key new member to our board of directors. Dr....

Innovus (INNV) in Silicon Review Interview.

POISED FOR INNOVATION. The Silicon Review is the world’s most trusted online and print community for business & technology professionals. Our community members include thought-provoking...
internet stock review

Innovus (INNV) Conference Call Transcript.

Q1 2019 Results, 5/15/19.  Innovus Pharmaceuticals, Inc. (OTCQB:INNV) Q1 2019 Earnings Conference Call May 15, 2019 4:15 PM ET Company Participants Bassam Damaj - President and CEO Ryan...
internet stock review

Innovus (INNV) Conference Call Today 5/15/19 at 4:15 EST.

The Company will host a conference call on Wednesday, May 15, 2019 at 4:15 p.m. ET/1:15 p.m. PT to discuss the financial results and...
biotech stock review, zestra

Innovus Pharma (INNV) Partners With Lavasta’s 150 Member Sales Force for Female Sexual Arousal!

Dubai based Lavasta is a pharmaceutical marketing company that offers niched unique medications based on the latest scientific innovations that defy current therapeutic conventions....
candida auris, citius pharma, biotech stock review

Citius Pharma’s (CTXR) Mino-Lok® Highly Efficacious in Rapidly Eradicating Candida auris.

CRANFORD, N.J., May 13, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") (Nasdaq: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, provided...
hotel communication network

Kevin Bidner’s Hotel Communication Network.

Click to Read About the Most Exciting Internet Powered Media Network (Advertising) We've Seen in Decades. The last time we saw a network like this...

Latest article

Could a Record El Niño Ignite the Next Vaccine Trade?

Chikungunya, Dengue Fever, Rift Valley Fever and Zika The Coming El Niño: An Overlooked Catalyst for Vaccine Stocks? Investors obsess over interest rates, tariffs and AI....

Party Time at UniQure (QURE)! From $8.86 to $47.21, up 432%.

I. No Bells, No Baskets.UniQure (QURE) $47 up Huge. Still Not Out Of The Woods!II.Replimune (REPL) $11.23. Gains 28% in Sympathy with UniQure. We...

Adding Bavarian Nordic (BVNRY) $8.91, to Watch List.

Bavarian Nordic Lands $106 Million Contract for its Smallpox/Mpox Vaccine! Were Back for the Third Time! LIVE QUOTE PREVIOUS WRITEUPS Aug 27, 2025: Our 4th Billion Dollar Takeover!...